Table II.
Serum concentration of angiogenin and SDF-1α among SSc and control groups
| Serum concentration [ng/ml] | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Angiogenin | SDF-1α | ||||||||||||
| n | Mean | Median | Min. | Max. | SD | n | Mean | Median | Min. | Max. | SD | ||
| SSc | 35 | 322.48 | 329 | 28 | 551 | 96.05 | 17 | 2.594 | 2.601 | 2.015 | 3.675 | 0.411 | |
| dSSc | 10 | 327.60 | 310 | 255 | 495 | 71.22 | 7 | 2.653 | 2.597 | 2.223 | 3.473 | 0.418 | |
| Control | 25 | 255.31 | 249 | 177 | 336 | 39.48 | 16 | 2.746 | 2.662 | 2.084 | 3.954 | 0.442 | |
Angiogenin: lSSc-dSSc: p = 0.978219; lSSc-Control: p = 0.000684; dSSc-Control: p = 0.001230
SDF-1α: lSSc-dSSc: p = 0.974667; lSSc-Control: p = 0.249042; dSSc-Control: p = 0.639997
n – number of patients, SSc – systemic sclerosis group, Control – control group, SD – standard deviation